January 2026 in “Pharmaceutical journal/The pharmaceutical journal” The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that additional information regarding psychiatric and sexual side effects will be included in the product information for medications containing finasteride and dutasteride. This decision follows a review of evidence for both drugs, as detailed in a drug safety update published on 11 May 2026. The MHRA recommends further measures to address these concerns.
June 2017 in “Reactions Weekly” Finasteride (Propecia) may cause depression and suicidal thoughts; stop use and inform a healthcare professional if symptoms develop.
August 2017 in “Drug and Therapeutics Bulletin” Finasteride may cause depression, suicidal thoughts, and sexual side effects.
1 citations
,
March 2013 in “The European Journal of Contraception & Reproductive Health Care” The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.
June 2024 in “Drug and therapeutics bulletin” Finasteride can cause depression, suicidal thoughts, and lasting psychiatric and sexual issues.